NEUP · Neuphoria Therapeutics Inc.

$3.79 +0.03 (+0.80%)

Market Cap

$20.32M

5.40M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Spyros Papapetropoulos	M.D., PhD President and Chief Executive Officer Tim Cunningham Chief Financial Officer Tim Cunningham Chief Financial Officer	$550,000	$226,875	—	$123,660	—	$50,808	$951,343

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Spyros Papapetropoulos	M.D., PhD President and Chief Executive Officer	$525,000	$196,875	—	—	—	$30,000	$751,875

Key facts CIK 1191070 CUSIP 64136E102 13F (30d) 20 filings 20 filers Visit website Investor relations